|
May 31
|
Netflix Stock Faces Test Of Time As IBD 50 Oil Stock Nears 10-Bagger Status
|
|
May 31
|
Ozempic Maker Novo Nordisk Stock Up More Than 31% In 2024, But Is It Too Late To Buy Shares?
|
|
May 31
|
Goldman Sees Obesity-Drug Market Growing to $130 Billion by 2030
|
|
May 30
|
Ro CEO on GLP-1 drug shortage: US healthcare is '1 of 1'
|
|
May 30
|
Goldman Sachs Says Buy European Pharma Stocks Touting Innovation
|
|
May 28
|
Nvidia, advances in cancer research, climate change under Trump: Market Domination
|
|
May 28
|
Sector Update: Health Care Stocks Fall Late Afternoon
|
|
May 28
|
SSE-backed wind farm fined record £33m for pushing up household bills
|
|
May 28
|
Sector Update: Health Care Stocks Retreat Tuesday Afternoon
|
|
May 28
|
Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System
|
|
May 28
|
Dow Jones Tech Giant Apple, AI Leader CrowdStrike Eye Buy Points
|
|
May 28
|
Market Chatter: Novo Nordisk Tells US Senate Health Committee Chair Sanders It Only Keeps 60% of Ozempic, Wegovy List Price
|
|
May 28
|
Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?
|
|
May 28
|
Analysis-Weight-loss drug forecasts jump to $150 billion as supply grows
|
|
May 24
|
Top Midday: Intuit, Workday Shares Tumble on Lowered Guidance; Ozempic Reduces Kidney Disease Events, Deaths From Cardiovascular Causes; NHTSA Finds 9 Additional Incidents Tied to Waymo
|
|
May 24
|
FDA advisory committee reviews Novo Nordisk insulin icodec for T1D
|
|
May 24
|
Novo’s Ozempic Slashes Risk of Death in Kidney Disease Study
|
|
May 23
|
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Qualcomm, Caterpillar, CSP and Epsilon Energy
|
|
May 23
|
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
|
|
May 22
|
Novo Nordisk's Once-Weekly Insulin Flagged With Risk Of Low Blood Sugar Ahead Of FDA Review
|